Dietmar Berger Gilead Sciences, Inc. (GILD) insider trading activity

GILD Quotes by TradingView

Dietmar Berger is Chief Medical Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 9,382 shares of GILD, which is worth approximately $1.16 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 6,944 shares (Common Stock) at a price of $121.6 per share, resulting in proceeds of $844,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.38K
n/a 3M change
n/a 12M change
Total Value Held $1.16 Million

Dietmar Berger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
SELL
Payment of exercise price or tax liability
$844,390 $121.6 p/Share
6,944 Reduced 42.53%
9,382 Common Stock
Jan 02 2026
BUY
Exercise of conversion of derivative security
-
16,326 Added 50.0%
16,326 Common Stock
DB

Dietmar Berger

Chief Medical Officer
Foster City, CA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GILD